15 May with lectureScaling science into impact: the role of research platforms and public-private partnership) by Uppsala University Professor Anders Karlén will take place on the festivals' Deep Tech Stage. Professor Anders Karlén from Uppsala University took to the stage.
His research focuses on the identification of starting materials and the development of potential drugs for antimicrobial drug discovery. Between 2014 and 2021, Prof. Karlén was the head of the lead unit and co-coordinator of the Innovative Medicines Initiative (IMI) project ENABLE. He is currently the coordinator of the national project ENABLE-2, the follow-up to ENABLE. Since 2019, he is leading the six-year IMI-2 project COMBINE, part of the IMI Antimicrobial Resistance (AMR) Accelerator Initiative.
Prof. Karlén outlined the contribution of the ENABLE platform to addressing the needs of the pharmaceutical industry and public health.
This was followed by Panel discussionThe future of innovation: industry collaboration and sustainable science funding at 15.50.).
Experts - Jurģis Miezainis, Parliamentary Secretary, Ministry of Economics of the Republic of Latvia, Vitālijs Skrīvelis, PharmIdea SIA Board Member and Co-Owner, Osvalds Pugovičs, Deputy Director of the Latvian Institute of Organic Synthesis and BioPhoT Platform Manager, Joanna Lipner, Picralida co-founder and Executive Director - moderated by Sandra Kropa, will discuss how long-term financial support fosters scientific discovery and accelerates technology commercialisation.
Photo by publicity and Lauris Viksne.
